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Acute, but not chronic, metabolic acidosis disturbs 25-hydroxyvitamin
D3 metabolism. Previous studies in vitamin D deficient animals showing
that acidosis may impair the production of I ,25(OH)2D3 are in conflict
with studies in humans which have not shown convincing disturbances
of 250HD3 metabolism during acidosis. We have investigated the effect
on renal 250HD3 1- and 24-hydroxylase of acid loading for periods of 24
hr to 21 days. Acid loading resulted in immediate and sustained
decrements in arterial pH and bicarbonate and increments in blood-
ionized calcium. Acute (24-hr) acid loading decreased I- and increased
24-hydroxylase activity. After 6 days of acid loading, no effect on 1-
hydroxylase activity was observed and that on 24-hydroxylase activity
was reduced. By 21 days the effect of acidosis on 24-hydroxylase
activity was no longer observed. The results show that acidosis disturbs
250HD3 metabolism in the physiological vitamin D and calcium replete
state as well as in the vitamin D deficient state, but only acutely. Our
data are consistent with studies in humans and suggest that, while short-
term disturbances of 25OHD3 metabolism occur early in acidosis, they
are transient and may not be causally related to the development of
metabolic bone disease during chronic acidosis.
L'acidose metabolique aigue et non chronique perturbe le métabolisme
de Ia 25-hydroxyvitamine D3. Des etudes antérieures chez des animaux
déficients en vitamine D indiquant que l'acidose pourrait altérer Ia
production de l,25(OH)2D3 sont en conflit avec des etudes chez les
humains, qui n'ont pas montré d'anomalie convaincante du métabo-
lisme de Ia 250HD3 pendant l'acidose. Nous avons étudié l'effet sur Ia
25OHD3 I- et 24-hydroxylase rénale d'une charge acide pendant des
périodes de 24 heures a 21 jours. La charge acide a entrainé des
diminutions immédiates et prolongees du pH artériel et des bicarbon-
ates, et des augmentations du calcium ionisé sanguin. Une charge aiguë
(24 heures) a diminué l'activité de Ia 1- et augmenté celle de Ia 24-
hydroxylase. Aprés 6jours de charge acide, aucun effet sur l'activité I-
hydroxylase n'a été observée, et celui sur l'activité 24-hydroxylase était
réduit. Au bout de 21 jours, l'effet de l'acidose sur l'activité 24-
hydroxylase n'était plus visible. Ces résultats montrent que l'acidose
altére le métabolisme de la 250HD3 lors d'un état physiologique en
vitamine D et en réplétion calcique, comme dans un état de déficience
vitaminique D, mais seulement de facon aigue. Nos données sont
compatibles avec les etudes chez les humains et suggèrent que bien que
des alterations du mCtabolisme de Ia 250HD3 a court terme puissent se
produire tot en acidose, celles-ci sont transitoires, et ne sont probable-
ment pas reliées au dCveloppement d'une ostéopathie métabolique
pendant l'acidose chronique.
The similarity between the skeletal abnormalities observed in
acidotic states and those of vitamin D deficiency or in subjects
with disordered vitamin D metabolism has led to the suggestion
that an acidosis-induced disturbance of vitamin D metabolism
may contribute to the genesis of this type of bone disease [1, 21.
Studies in vitamin D-depleted chicks and rats have shown that
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acidosis induced by feeding ammonium chloride (NH4C1) is
associated with decreased conversion of 25-hydroxyvitamin D3
(250HD3) to 1,25-dihydroxyvitamin D3 [l,25(OH)2D3], both in
vivo [3—5] and in vitro [4, 6, 7]. If these apparent disturbances of
250HD3 metabolism are a direct consequence of the acid
loading, the possibility of diminished production of
1,25(OH)2D3 leading to widespread alterations of mineral and
skeletal metabolism exists, Alternatively, if the change in
250HD3 metabolism is merely a compensation for other effects
of acidosis on mineral metabolism, such as increased ionized
calcium concentration, it is much less likely that acidosis-
induced alterations of 250HD3 metabolism are causally related
to metabolic bone disease seen in chronically acidotic humans
and animals.
Although impairment of 1 ,25(OH)2D3 production during aci-
dosis has been shown in vitamin D replete animals, this effect
could only be demonstrated under conditions of calcium depri-
vation [8], and it is not known whether acidosis may disturb
250HD3 metabolism in the more physiological vitamin D and
calcium replete states.
The acute animal studies described above have yielded
results different from those of the effect of induced [9—11] or
spontaneous [12] metabolic acidosis in humans. These studies
have not shown measurably disturbed vitamin D metabolism
during acidosis,
In an attempt to resolve some of these questions, we have
performed experiments using both vitamin D deficient and
replete rats and have endeavored to relate the disturbed
250HD3 metabolism associated with acid loading to the chro-
nicity of the acidosis and to concomitant changes in pH,
calcium, and inorganic phosphorus.
Methods
Animals. Male Lewis rats (Charles River Laboratories, Wil-
mington, Massachusetts) were placed on a vitamin D deficient
diet containing 0.2% calcium and 0.4% phosphorus (Teklad,
Madison, Wisconsin) at the time of weaning. The animals were
reared in the dark and studied after 7 weeks on the diet. Some
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experiments were performed using Lewis rats reared on a
nutritionally complete diet containing vitamin D 113 LgIkg,
1.2% calcium, and 0.8% phosphorus (Diet 5001, Ralston Purina,
St. Louis, Missouri) until they were 10 weeks old.
Acidosis was induced by giving drinking water containing
either 0.3 M NH4CI (to vitamin D deficient rats) or 0.4 M NH4CI
(to vitamin D replete rats) for periods of 1, 6, or 21 days prior to
experimentation. To eliminate interassay variation and to mini-
mize errors arising from the use of different batches of animals,
each treatment group was compared with a simultaneously
studied control group.
Enzyme assays. Direct assays of mitochondrial 250HD3 1-
and 250HD3 24-hydroxylase activity were performed separate-
ly on the mitochondria from each animal by a method adapted
from that of Vieth and Fraser [13]. This technique has been
shown to result both in a linear time course of product forma-
tion up to 20 mm for 1-hydroxylase and to 30 mm for 24-
hydroxylase and in a linear relationship between I ,25(OH)2D3
or 24,25-dihydroxyvitamin D [24,25(OH)2D3] production and
mtochondrial protein concentration up to at least 5 mg/ml [131.
The kidneys were removed, weighed, stripped of connective
tissue and fat, diced and homogenized in 15 vol (v/w) of ice-cold
buffer (250 m sucrose, 10 mii KCI, 10 mrvi Hepes, and 2 mM
EGTA) with the pH adjusted to 7.4 at 25°C. The homogenate
was centrifuged at x4,000g for 40 sec and the supernatant
recentrifuged at x9,000g for 20 mm. The resulting pellet,
consisting mainly of mitochondria, was resuspended in ice-cold
incubation medium (125 mM KC1, 20 mrvi Hepes, 10 mii L-malic
acid, 2 mi MgSO4, and 0.25 mri EGTA, pH 7.0 at 25°C). Prior
to incubation, mitochondrial protein concentration was adjust-
ed to approximately 4 mg/mI pending definitive assay [14].
Incubations were carried out in a shaking incubator at 25°C
using 1 ml of mitochondrial suspension gassed with 100% 02.
After a 3-mm preincubation, 500 pmoles of 250HD3 containing
20,000 dpm of 26,27-3H 250HD3 were added in 20 pJ of
acetone. The reaction was terminated after 20 mm by the
addition of 3.75 ml of methanol:chloroform (2:1), containing
0.017% butylated hydroxytoluene. Appropriate blanks using
boiled mitochondria were included in all experiments.
Extraction, separation, and identification of metabolites. In
all experiments lipid extraction was by a modified [13] method
of Bligh and Dyer [15]. Separation of radioactive vitamin D
metabolites was accomplished by high pressure liquid chroma-
tography (HPLC), using a Rad-Pak Sil 0.5 x 10 cm analytical
column with 10 m packing (Waters Associates, Milford,
Massachusetts), eluted with methylene chloride:methanol
(98:2), at a flow rate of 3 ml/min. Solvent delivery was by a
model 6000A pump linked to a U6K injector and to a model 440
UV detector (all equipment from Waters Associates). Frac-
tions of 0.75 ml were collected and evaporated; radioactivity
was determined by liquid scintillation spectroscopy. In all
HPLC separations a Corasil II Guard Column was used to
protect the analytical column. Radioactive peaks were identi-
fied provisionally by co-chromatography with authentic unla-
belled 250HD3, 24,25(OH)2D3, 25,26-dihydroxyvitamin D3
[25,26(OH)2D3], 1 ,25(OH)2D3, and 1 ,24,25-trihydroxyvitamin
D3 [l,24,25(OH)3D3]. The putative l,25(OH)2D3 peak was re-
chromatographed on a different straight phase system using a
3.9 mm x 36 cm .t-Porasil column (Waters Associates) eluted
with hexane:isopropanol (90:10). The putative 24,25(OH)2D3
peak was subjected to treatment with sodium metaperiodate
[16] and also to rechromatography on a -Porasil column eluted
with methylene chloride:isopropanol (99:1).
Calculations. Preliminary experiments demonstrated that the
recovery of tritiated 25011D3, 24,25(OH)2D3, and 1 ,25(OH)2D3
following the extraction and initial straight phase HPLC de-
scribed above was essentially the same for each of the three
metabolites, averaging 87%. This allowed the calculation of
enzyme activity from the amount of radioactivity appearing as
product expressed as a fraction of total radioactivity recovered.
The amount of product formed was corrected for mitochondrial
protein concentration. Enzyme activity was expressed as fern-
tomoles of product produced per milligram of mitochondrial
protein per minute, Group data are expressed as the mean
SEM. Student's t test for unpaired data was used to determine
the significance of differences between groups; a value of P <
0.05 was regarded as significant.
Chemical determinations. All radiolabelled compounds were
purchased from Amersham Searle, Arlington Heights, Illinois.
Nonradioactive 250HD3 was a gift from Upjohn (Kalamazoo,
Michigan). The 24,25(OH)2D3, 25,26(OH)2D3, l,25(OH)2D3,
and l,24,25(OH)3D3 were gifts from Dr. M. R. Uskokovic of
Hoffrnann-LaRoche (Nutley, New Jersey). All other chemicals
and solvents were commercially supplied. Total calcium [17]
and inorganic phosphorus [18] were measured in plasma as
previously described. Blood-ionized calcium was measured
with an ionized calcium analyzer (Model SS-20, Orion Biomedi-
cal, Cambridge, Massachusetts). Arterial pH and Pco2 were
measured using a blood gas analyzer (Corning 175, Coming
Medical, Medfleld, Massachusetts) and bicarbonate concentra-
tion was calculated from the Henderson Hasselbach equation.
Results
Characterization of vitamin D metaholites. Typical chro-
matograms of lipid extracted after incubation with mitochondria
from vitamin D deficient and vitamin D replete rats are shown
in Figure 1. When the 1 ,25(OH)2D3 peak from the initial straight
phase HPLC using the Rad-Pak Sil column was rechromato-
graphed on a -Porasil column eluted with hexane:isopropanol
(90:10), 82% of the applied radioactivity cornigrated with au-
thentic unlabelled 1 ,25(OH)2D3 (Fig. 2). Treatment of the
24,25(OH)2D3 peak from the initial straight phase HPLC with
sodium metaperiodate resulted in loss of 85% of the lipid
extractable radioactivity. When the 24,25(OH)2D3 peak was
rechromatographed on a -Porasil column eluted with methyl-
ene chloride:isopropanol (99:1), 79% of the applied radioactiv-
ity was recovered comigrating with authentic unlabelled
24,25(OH)2D3 (Fig. 2).
Mitochondria from vitamin D deficient rats produced signifi-
cant amounts of 1 ,25(OH)2D3 but no detectable 24,25(OH)2D3,
25,26(OH)2D3, or 1,24,25(OH)3D3. Conversely, mitochondria
from vitamin D replete rats produced 24,25(OH)2D3 and only
very small amounts of material which cornigrated with authen-
tic 25,26(OH)2D3 and 1,25(OH)2D3 on initial straight-phase
HPLC. Rechromatography of these materials on a -Porasil
column eluted with hexane:isopropanol (90:10), resulted in a
loss of 60 to 75% of radioactivity cornigrating with authentic
standards. Thus, the production of 25,26(OH)2D3 and
1,25(OH)2D3 by mitochondria from vitamin D replete rats was
minimal and could not be quantitated reliably.
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Effect of acid loading. In all experiments, NH4C1 loading
induced a marked and sustained acidosis as manifest by de-
creases in blood pH and bicarbonate concentration (Table 1).
In vitamin D-depleted rats, acute (24 hr) acid loading was
associated with a marked increment in plasma ionized calcium
(3.5 0.2 vs. 2.5 0.2 mg/dl, P < 0.001). Plasma total calcium
increased in parallel with ionized calcium (6.6 0.3 vs. 5.4
0.4 mg/dl, P < 0.002). Plasma phosphate did not change
significantly (Table 1). In the control animals, 250HD3 1-
hydroxylase activity, measured separately in each animal, was
105 17 fmoles min' mg, a value that agrees with previous
work [19]. Acute (24-hr) acid loading resulted in a substantial
decrement in 1-hydroxylase from 105 17 fmoles min mg'
in the control animals to 66 8 fmoles min' mg' in the
acidotic animals (Fig. 3).
Elution volume, ml
Fig. 2. A Rechroinatography of the putative 24,25(OH),D1 peak from
the initial HPLC shown in Figure IC. The -Porasil column was eluted
with methylene chloride:isopropanol(99:1) at 2 mI/mm. B Rechromato-
graphy of the putative I ,25(OH)2D1 from the initial HPLC shown in
Figure lB. The js-Porasil column was eluted with hexane:isopropanol
(90:10) at 2 mI/mm. Vertical arrows indicate the positions of unlabelled
standards.
In contrast, after 6 days of acid loading, the suppression of 1-
hydroxylase in the acidotic animals was no longer observed (95
12 fmoles min' mg' in the control animals versus 84 12
fmoles min mg in acidotic animals) despite higher plasma
ionized calcium concentrations in the acidotic animals. Plasma
phosphate was not altered significantly by NH4CI feeding for 6
days.
In vitamin D and calcium replete rats, a similar tendency of
acid loading to elevate plasma ionized calcium was seen (Table
1). As was the case with the vitamin D deficient animals, the
experiments using vitamin D replete rats showed a time-
dependent influence of acid loading on 250HD3 metabolism. In
these animals, 24,25(OH)2D3 was the only metabolite produced
in measurable quantities (Fig. 1). After 24 hr of acid loading,
blood-ionized calcium was elevated significantly (5.1 0.1 vs.
4.5 0.1 mg!dl, P < 0.001), although total plasma calcium did
not differ significantly between acidotic and control groups.
Plasma phosphate decreased slightly following acute acid load-
ing. These changes were accompanied by a marked increase in
24-hydroxylase activity from 143 68 to 530 59 fmoles min'
mg', P < 0.001 in the acidotic animals (Fig. 3). After 6 days,
the augmentation of 24-hydroxylase by acidosis was reduced,
though still significant (207 30 vs. 119 10 fmoles min
mg, P < 0.025), despite an increment in plasma ionized
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Fig. 1. A HPLC profile of unlabelled standards, B labelledmetabolites
following incubations with mitochondria from vitamin D deficient rats,
and C following incubations with mitochondria from vitamin D replete
rats. A Rad Pak Sil radial compression column was eluted with
methylene chloride:methanol (98:2) at 3 mI/mm (see Results).
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N pH HCO Ca Cat P1
Vitamin D deficient
24-hr acidosis
Control 8 7.35 0.03
P < 0.001
25.1 0.5
P < 0.001
2.5 0.2
P < 0.01
5.4 0.4
P < 0.02
6.5 0.5
NS
Acidotic 10 7.15 0.04 13.2 1.3 3.5 0.2 6.6 0.3 6.3 0.2
Vitamin D deficient
6-day acidosis
Control 6 7.27 0.02
P < 0.02
23.8 0.8
P < 0.01
2.0 0.1
P < 0.05
4.9 0.2
NS
7.0 0.6
NS
Acidotic 8 7.16 0.03 15.0 1.2 2.7 0.3 5.6 0.3 5.6 0.3
Vitamin 0 replete
1-day acidosis
Control 8 7.39 0.01
P < 0.001
28.0 0.7
P < 0.001
4.5 0.1
P < 0.001
10.6 0.2
NS
8.9 0.3
P < 0.02
Acidotic 12 7.23 0.02 15.0 0.6 5.1 0.1 10.9 0.1 7.7 0.3
Vitamin D replete
6-day acidosis
Control 8 7.42 0.01
P < 0.001
28.0 0.8
P < 0.001
4.5 0.1
P < 0.001
10.3 0.1
NS
8.1 0.4
P < 0.01
Acidotic 8 7.21 0.02 15.8 0.4 5.2 0.1 10.5 0.1 6.7 0.2
Vitamin D replete
21-day acidosis
Control 8 7.35 0.02
P < 0.01
27.3 0.6
P < 0.001
4.5 0.1
P < 0.001
10.9 0.2
P < 0.05
8.0 0.2
P < 0.02
Acidotic 10 7.26 0.02 20.0 0.6 5.1 0.1 10.3 0.2 7.1 0.2
calcium and severity of acidosis similar to that seen at 24 hr.
Total calcium was comparable in control and acidotic animals,
but plasma phosphate was decreased slightly by 6 days of acid
loading. By 21 days, although the tendency of acid loading to
elevate ionized calcium persisted and was comparable to that at
24 hr and 6 days, the augmentation of 24-hydroxylase activity
by acidosis was no longer observed (137 19 vs. 152 29
fmoles mm' mg in control and acidotic animals, respective-
ly). Plasma total calcium and phosphate in rats that had been
acid-loaded for 21 days were both slightly lower than in control
rats.
Discussion
These results show that the responses of the renal 250HD3 1-
and 24-hydroxylases to acute experimentally induced acidosis
are qualitatively different from those seen after more prolonged
acidosis of 6 or more days duration. The data show that
acidosis-induced changes in 250HD3 metabolism are not con-
fined to vitamin 0 and calcium-depleted animals but are demon-
strable in the more physiological vitamin D and calcium replete
state as well.
The control of 250HD3 metabolism to 1 ,25(OH)2D3 and
24,25(OH)2D3 is mediated by a variety of hormonal [20—25] and
ionic [26—29] factors, of which calcium, phosphate, and PTH
are probably the most important. Metabolic acidosis appears to
suppress 1-hydroxylase by inhibiting PTH sensitive adenylate
cyclase without affecting post c-AMP events [6]. However,
little is known of the potential of the renal 250HD3 hydroxyl-
ases to lose their responsiveness to a perturbation that is
maintained for an extended period, although other aspects of
renal function do exhibit adaptive responses to certain condi-
tions, such as acid loading [30—321.
Our demonstration of a clear-cut suppression of 1-hydroxyl-
ation of 250HD3 during short-term (24 hr) acidosis, with an
accompanying increase in ionized calcium from 2.5 to 3.5 mg/dl,
without changes in plasma phosphate, suggest calcium as a
likely mediator of the suppression of 1-hydroxylase by acidosis.
Previous studies in vitamin D deficient chicks have shown that
modest increments in plasma calcium, induced by increasing
dietary calcium, caused marked suppression of 1-hydroxylase
activity, although calcium rose only slightly and remained in the
hypocalcemic range [33, 34].
When we studied rats that had been acid-loaded for 6 days,
the initial suppression of 1-hydroxylase, seen at 24 hr, was no
longer apparent. This change occurred although blood-ionized
calcium remained elevated in the acidotic animals and the
severity of acidosis was comparable to that at 24 hr.
The experiments done on vitamin D replete animals showed
that the 24-hydroxylase exhibited a time course of adaptation
similar to that of 1-hydroxylase. In these rats, acute (24 hr)
acidosis induced very large increases in 24-hydroxylase activi-
ty, with an associated increase in blood-ionized calcium from
4.5 to 5.1 mg/dl. Parathyroidectomy has been shown to increase
24-hydroxylase activity in vitamin D replete rats [191, and it is
possible that the increment in ionized calcium in the acidotic
animals, by decreasing PTH production, increases 24-hydroxy-
Table 1. Effect of ammonium chloride loading on pH, bicarbonate (HCOfl, ionized calcium
phosphorus (Pi) in ratsa
(Ca), total calcium (Cat), and inorganic
Vitamin D deficient and replete rats were given ammonium chloride for periods of 24 hr, 6 days, or 21 days. Data shown are mean SaM of
measurements made on aortic blood samples.
Fig. 3. A In vitro kidney 250HD3 1-
hydroxylase activity in vitamin D deficient rats
after ammonium chloride loading for 24 hr or
6 days. Incubations of mitochondria from each
animal were performed in duplicate. Vertical
bars represent the mean SEM of values
obtained from 6 to 12 rats per group. B In
vitro kidney 24-hydroxylase activity in vitamin
D replete rats after ammonium chloride
loading for 24 hr, 6 days, or 21 days. Data are
the mean SEM of duplicate incubations
performed separately on each of 8 to 12 rats
per group.
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lase activity by this mechanism. Furthermore, the anticalciuric
action of PTH on the kidney is impaired during metabolic
acidosis [35] and, although an effect of acidosis on target organ
responsiveness to PTH has been questioned recently [36], it is
possible that the normal action of PTH to stimulate 1-hydroxy-
lase and suppress 24-hydroxylase is impaired by acidosis. After
acid loading for 6 days, the influence of acidosis on ionized
calcium was the same, but that on 24-hydroxylase activity was
much less. After 21 days, the increment in ionized calcium in
the acidotic animals was still the same as at earlier time points,
but there was now no effect of acidosis on 24-hydroxylase
activity.
The increments in blood-ionized calcium that we have docu-
mented during acidosis were marked and may have resulted
from decreased binding of calcium to plasma protein, or from
the entry of a large amount of skeletal calcium into the
extracellular fluid as the acid load was partially buffered by
alkaline bone salts [37]. Plasma phosphate was slightly lower in
the acidotic animals and therefore hyperphosphatemia cannot
be implicated as a mediator of the effects of acidosis. The
finding that acidosis leads to reciprocal changes of 1- and 24-
hydroxylase activity indicates that a direct toxic effect of
NH4C1 or acidosis on the 250HD3 hydroxylases is an unlikely
explanation for our observations.
The complementary adaptive changes in two closely related
enzyme systems, occuring within 6 days of the onset of
acidosis, does not agree with certain previous studies. Thus,
Kawashima, Kraut, and Kurokawa [6], using dissected rat
nephron segments and Reddy et al [7], using isolated perfused
rat kidneys, have shown decreased 1-hydroxylase in vitro
following 7 and 9 days, respectively, of NH4C1 loading. Fur-
thermore, Kawashima's studies showed unimpaired 1-hydrox-
ylation of 250HD3 after acute (16 hr) acidosis. The reason for
these inconsistencies is unclear, although the differences be-
tween the assay techniques used may be important.
It is known that the kidney may adapt to chronic acidosis in
several ways, including macroscopic hypertrophy [30], stimula-
tion of renal gluconeogenesis [31], and increased renal ammonia
excretion [32]. These changes do not occur instantaneously but
may take several days to manifest fully [32]. However, although
these adaptive phenomena show a time course which approxi-
mates the adaptation of the 250HD3 1-hydroxylases during acid
loading, we can only speculate on their relationship to the
mechanism by which the hydroxylases adapt. That the adapta-
tion occurs while blood-ionized calcium, pH, bicarbonate and
inorganic phosphate concentrations are constant suggests that
some other parameter, or parameters, of the acidotic state must
operate early, but not late, in acidosis to mediate the influence
of acidosis on the metabolism of 250HD3. Alternatively, an
initial influence of acidosis (either direct or indirect) on the
renal 250HD3 hydroxylases may subsequently be opposed by
delayed compensatory mechanisms which become more domi-
nant as the duration of acid loading increases.
Our results, with recent data from Bushinsky et al [81
showing that suppression of plasma 1 ,25(OH)2D3 in the acid-
loaded rat is only apparent when the 1-hydroxylase has been
stimulated previously by dietary calcium restriction, may ex-
plain why disturbances of vitamin D metabolism have not been
seen in chronically acidotic, vitamin D, and calcium replete
humans. The present studies are compatible with data obtained
from volunteers with induced acidosis [9—11] and from patients
with severe spontaneous acidosis [121. The results support the
view that, while short-term disturbances of 250HD3 metabo-
lism may occur during the development of acidosis, such
disturbances are transient and probably not causally related to
the development of metabolic bone disease during chronic
acidosis.
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